NCT02026583 2018-01-17
A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer Patients
Samsung Medical Center
Phase 2 Completed
Samsung Medical Center
Samsung Medical Center
Samsung Medical Center